Apellis Pharmaceuticals (APLS) PT Raised to $60 at Wedbush
Tweet
Share
E-mailGet Alerts APLS Hot Sheet
Price: $41.03 --0%
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Wedbush analyst Laura Chico raised the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $60.00 (from $39.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Goldman Sachs Upgrades Plains All American (PAA) to Neutral
- Seiko Group Corp (8050:JP) PT Raised to JPY7,400 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
